Gene · 10397
Papers3,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of Pathogenicity and Causativity of Variants in the MPZ and SH3TC2 Genes in a Family Case of Hereditary Peripheral Neuropathy. | Int J Mol Sci | 2023 | 37372933 | PubTator, text mining | PubMed |
| Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms. | Cancers (Basel) | 2023 | 37370750 | PubTator, text mining | PubMed |
| Expression Profile of miR-199a and Its Role in the Regulation of Intestinal Inflammation. | Animals (Basel) | 2023 | 37370489 | PubTator, text mining | PubMed |
| Role of KLF4/NDRG1/DRP1 axis in hypoxia-induced pulmonary hypertension. | Biochim Biophys Acta Mol Basis Dis | 2023 | 37356737 | PubTator, text mining | PubMed |
| Globally invariant behavior of oncogenes and random genes at population but not at single cell level. | NPJ Syst Biol Appl | 2023 | 37355674 | PubTator, text mining | PubMed |
| The GR-SGK1-NDRG1 Pathway as a Predictor of Recurrence and Prognosis in Lung Adenocarcinoma After Radical Surgery. | Anticancer Res | 2023 | 37351994 | PubTator, text mining | PubMed |
Human adenovirus DNA polymerase is evolutionarily and functionally associated with human telomerase reverse transcriptase based on in silico molecular characterization that implicate abacavir and zidovudine. | Front Bioinform | 2023 | 37351013 | PubTator, text mining | PubMed |
| Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics. | Front Pharmacol | 2023 | 37346302 | PubTator, text mining | PubMed |
| Re-Shaping the Pancreatic Cancer Tumor Microenvironment: A New Role for the Metastasis Suppressor NDRG1. | Cancers (Basel) | 2023 | 37345116 | PubTator, text mining | PubMed |
| Phosphatases maintain low catalytic activity of SGK1: DNA damage resets the balance in favor of phosphorylation. | J Biol Chem | 2023 | 37343701 | PubTator, text mining | PubMed |
| Significance of liquid-liquid phase separation (LLPS)-related genes in breast cancer: a multi-omics analysis. | Aging (Albany NY) | 2023 | 37338518 | PubTator, text mining | PubMed |
| Scutellaria baicalensis enhances 5-fluorouracil-based chemotherapy via inhibition of proliferative signaling pathways. | Cell Commun Signal | 2023 | 37337282 | PubTator, text mining | PubMed |
| Vincristine-Induced Acrocyanosis and Erythema Pernio. | J Prim Care Community Health | 2023 | 37335086 | PubTator, text mining | PubMed |
| Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the HSP90A/NDRG1 pathway. | Cell Signal | 2023 | 37329997 | PubTator, text mining | PubMed |
| β-asarone inhibits the migration, invasion, and EMT of bladder cancer through activating ER stress. | Cancer Med | 2023 | 37306628 | PubTator, text mining | PubMed |
| mTOR Regulation of N-Myc Downstream Regulated 1 (NDRG1) Phosphorylation in Clear Cell Renal Cell Carcinoma. | Int J Mol Sci | 2023 | 37298315 | PubTator, text mining | PubMed |
| Awakening of Dormant Breast Cancer Cells in the Bone Marrow. | Cancers (Basel) | 2023 | 37296983 | PubTator, text mining | PubMed |
| N-myc Downstream Regulated Gene 1 Promotes Adipocyte Differentiation in Endothelial Cells of Infantile Hemangioma. | Ann Dermatol | 2023 | 37290956 | PubTator, text mining | PubMed |
| The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics. | Pharmacol Rev | 2023 | 37280098 | PubTator, text mining | PubMed |
| mTOR-inhibitors and post-transplant diabetes mellitus: a link still debated in kidney transplantation. | Front Med (Lausanne) | 2023 | 37250653 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10397/papers?page=17